CyberKnife Treatment in India: A Decision Briefing for Australian Patients

Author:- Dr. Dheeraj Bojwani Date Created:- 21-08-2026

CyberKnife is a genuinely remarkable technology, delivering precise, high-dose radiation without surgery, in far fewer sessions than conventional radiotherapy. This briefing sets out an honest picture of just how limited access to it remains in Australia, and why India's leading centres are a credible, well-evidenced option worth serious consideration. It's worth being precise about who this is for. CyberKnife suits a specific range of tumours and clinical situations, and this briefing is written for patients whose radiation oncologist has confirmed they're a genuine candidate, weighing where that treatment should happen.

Healing Journeys of Australian Patients

Australian Patients Share Their Experience

Key Takeaways

• This briefing is intended for Australian patients whose radiation oncologist has confirmed that they are a genuine candidate for CyberKnife and who are considering where treatment should take place. It focuses particularly on Australia's limited access to CyberKnife and India's greater depth of experience with the technology.
• Melbourne's CyberKnife centre, opened through a 2025–2026 joint venture, was described as Victoria's first CyberKnife facility and the first on Australia's entire east coast, showing how recently and selectively the technology has become available in Australia.
• CyberKnife can change the treatment timeline significantly. Conventional radiotherapy may involve approximately 30 sessions over several weeks, while CyberKnife can deliver treatment in around five sessions using sub-millimetre precision and real-time tumour tracking.
• India's leading cancer centres are presented as operating CyberKnife and equivalent stereotactic systems at genuine scale, supported by dedicated medical physics teams, current case volume, English-speaking specialists and internationally accredited hospitals. Owning the technology is not the same as having deep experience using it.
• The cost chart gives an illustrative private cost of approximately AUD $8,000 in India versus AUD $35,000 in Australia for a standard five-session stereotactic body radiotherapy course. Actual costs vary according to tumour location and the number of sessions required.
• Good CyberKnife care requires an honest candidacy assessment, a named medical physicist, genuine case volume with the exact technology, a clear follow-up imaging plan and transparent pricing.

Quick Facts

Treatment

CyberKnife Stereotactic Radiosurgery

Patients

Australian Patients

Key Specialist

Radiation Oncologist

Key Technology

Sub-millimetre precision and real-time tumour tracking

Typical Sessions

Around 5 sessions

Conventional Radiotherapy

Often several weeks of treatment

India Cost

Approx. AUD $8,000

Australia Cost

Approx. AUD $35,000

Australia Access

Recently expanded to the east coast

Quality Check

Exact CyberKnife case volume

Medical Physics

Named medical physicist responsible for planning

Hospital Check

JCI/NABH accreditation

Follow-Up

Imaging reviewed by Australian team

Treatment Timeline

Approximately 2–3 weeks

Visa

Indian e-medical and e-medical attendant visas

Author

Dr. Dheeraj Bojwani

Experience

24+ Years

In Brief

For Australian patients confirmed as suitable candidates for CyberKnife, the briefing highlights India's greater treatment volume, dedicated medical physics teams and established use of stereotactic technology. It gives an illustrative cost of approximately AUD $8,000 in India compared with AUD $35,000 in Australia for a five-session course, while noting that costs vary by tumour location and session requirements. Patients should confirm genuine candidacy, identify the medical physicist responsible for planning, verify exact technology-specific case volume and arrange Australian follow-up imaging before travelling.

In 24 years of guiding international patients into Indian hospitals, this is a genuine, current pattern worth understanding before anything else. Australia's east coast, home to the majority of the country's population, only gained its first CyberKnife facility very recently, through a joint venture explicitly framed as expanding access that has, until now, been genuinely scarce.

Why this technology changes the treatment timeline, not just the technique

This is one of the most practically important differences to understand. Conventional radiotherapy typically spans several weeks of daily visits. CyberKnife's sub-millimetre precision and real-time tumour tracking allow a comparable effective dose to be delivered in around five sessions, a genuinely different commitment for patients weighing treatment, particularly if travel is involved either way.

Why India specifically, not just overseas

This is worth spelling out plainly. India's leading cancer centres operate CyberKnife and equivalent stereotactic systems at a scale that reflects the size of the population they serve, with dedicated medical physics teams and case volume that a single, newly-opened facility cannot yet match. This is not a compromise reached for cost and speed; for the right case, it is comparable or greater depth of specific experience with this exact technology, delivered by English-speaking specialists in internationally accredited hospitals, at a fraction of the equivalent Australian private cost.

An honest cost comparison

These figures are illustrative and vary by tumour location and the number of sessions required, but the pattern holds consistently. Always insist on a written, itemised quote for your specific case before making any decision.

What Genuinely Good CyberKnife Care Looks Like, Wherever You Have Treatment

• An honest candidacy assessment. Not every tumour is a genuine CyberKnife candidate; ask directly why this technology suits your specific case.
• A named medical physicist. Ask who is specifically responsible for patient-specific quality assurance and planning for your treatment.
• Genuine case volume with this exact technology. Owning the machine is not the same as a team with deep, current experience using it.
• A clear follow-up imaging plan. Unlike surgery, results from radiosurgery take weeks to months to become apparent; confirm this is explained clearly.
• A clear, itemised quote before you travel. Confirm exactly how many sessions are included in the price.

Signals worth taking seriously, wherever you're considering treatment

A few patterns are worth watching for, regardless of which country or hospital you're evaluating. CyberKnife recommended without a genuine discussion of whether your specific tumour is actually a suitable candidate deserves a direct question in return. A price quoted before your imaging has been properly reviewed is another signal worth pausing on. Vagueness about the team's case volume with this exact technology, or no named medical physicist responsible for your specific treatment plan, are both genuine concerns worth taking seriously.

None of this is unique to overseas care; the same questions are worth asking of an Australian provider too. What changes when evaluating a hospital overseas is that you have fewer easy, informal ways to verify answers, which is exactly why insisting on things in writing, and on a proper video consultation with the radiation oncologist who will actually plan your treatment, matters more than it might at home.

Australia-specific considerations most patients miss

Ask your Australian radiation oncologist directly about CyberKnife candidacy. They are well placed to advise whether this technology genuinely suits your case, even without ready local access to it.

Arrange your follow-up imaging before you leave. Confirm your Australian team is willing to review results from treatment performed overseas over the following months.

Ask about the Medical Treatment Overseas Program. Where a specific technology is genuinely unavailable or has a long wait in Australia, this Commonwealth programme can in some circumstances fund treatment abroad.

Apply for both visas together. Australian passport holders are eligible for India's electronic medical visa, with an e-medical attendant visa for whoever travels with you.

A closing word

CyberKnife remains a genuinely rare technology across Australia, only recently reaching the country's east coast at all, and demand from a rising number of cancer diagnoses is only going to increase pressure on that limited capacity. For patients confirmed as genuine candidates, the case for India is a strong one: radiosurgery teams with deep, current experience at genuine scale, technology in routine daily use, and treatment that can typically begin within two to three weeks rather than facing a long wait for one of Australia's very few machines, at a fraction of the equivalent Australian private cost. In 24 years of helping patients navigate exactly this decision, the pattern holds: those who look closely at what India's leading radiosurgery centres actually offer generally come away reassured rather than anxious. Confirm genuine candidacy first, insist on a named medical physicist and clear case volume, and travel with a written, itemised quote in hand. If you would like a second opinion on your imaging, send it and I will look at it properly — including telling you if CyberKnife isn't the right technology for your case, which is an answer I give when it's true.

Frequently Asked Questions by Australian Patients about CyberKnife Treatment in India

Why might Australian patients consider CyberKnife treatment in India?

Australian patients may consider India because CyberKnife remains relatively limited in Australia, particularly on the east coast. The briefing highlights India's established treatment volume and specialist experience with the technology.

Is CyberKnife suitable for every Australian cancer patient?

No. The briefing specifically states that CyberKnife suits a particular range of tumours and clinical situations. Australian patients should first have their radiation oncologist confirm that they are a genuine candidate.

How does CyberKnife reduce the treatment schedule?

CyberKnife uses sub-millimetre precision and real-time tumour tracking, allowing the effective radiation dose to be delivered in around five sessions rather than the several weeks often associated with conventional radiotherapy.

How many CyberKnife sessions might Australian patients need?

The briefing uses approximately five sessions as the typical example for its comparison. The actual number depends on the tumour location and individual treatment plan.

How much does CyberKnife treatment cost in India for Australian patients?

The briefing gives an illustrative private cost of approximately AUD $8,000 in India, compared with approximately AUD $35,000 in Australia for a standard five-session course. Actual costs vary by tumour and session requirements.

What should Australian patients ask about CyberKnife experience in India?

They should ask for the centre's case volume with CyberKnife specifically, rather than accepting general radiation-treatment or equipment experience as evidence of expertise.

Why is a medical physicist important for CyberKnife treatment?

The briefing recommends identifying the named medical physicist responsible for patient-specific quality assurance and treatment planning, as this is an important part of safe and accurate radiosurgery.

What warning signs should Australian CyberKnife patients look for?

Patients should be cautious if CyberKnife is recommended without a proper candidacy discussion, pricing is given before imaging is reviewed, the centre cannot provide exact technology-specific case volume or no medical physicist is identified.

How should Australian patients arrange follow-up after CyberKnife in India?

Patients should arrange follow-up imaging before travelling and confirm that their Australian radiation oncology team will review treatment results over the following weeks or months.

What should Australian patients ask before choosing a CyberKnife centre in India?

They should ask whether their tumour is genuinely suitable, who the responsible medical physicist is, how many CyberKnife cases the team performs, how many sessions are required, what the quotation includes and who will review their follow-up imaging in Australia.

Sources

• Accuray, Icon Cancer Centre and 5D Clinics Joint Venture to Expand Access to Advanced Radiotherapy in Australia, 2025 — accuray.com
• Prostate Cancer Foundation of Australia, Precision Care: A New Era in Prostate Cancer Treatment — pcfa.org.au
• National Medical Commission — nmc.org.in
• National Accreditation Board for Hospitals & Healthcare Providers — nabh.co
• Atomic Energy Regulatory Board (licensed radiotherapy centres) — aerb.gov.in
• High Commission of India, e-Visa — indianvisaonline.gov.in

Page Summary

This five-page decision briefing examines CyberKnife treatment in India for Australian patients, focusing on Australia's limited access to the technology, the shorter treatment schedule compared with conventional radiotherapy, India's established CyberKnife experience and the importance of treatment-specific expertise. It includes an illustrative India-versus-Australia cost comparison, candidacy and quality checks, warning signs, a practical treatment timeline, Australian follow-up considerations, overseas funding possibilities, visa information and key questions patients should ask before choosing a CyberKnife centre.

Citation Block

Field	Information
Topic	CyberKnife Treatment in India for Australian Patients
Treatment	CyberKnife Stereotactic Radiosurgery
Patients	Australian Patients
Specialist	Radiation Oncologist
Treatment Sessions	Around 5 sessions
Key Technology	Real-time tumour tracking and sub-millimetre precision
India Expertise	High CyberKnife and stereotactic treatment volume
Medical Physics	Dedicated medical physics team
India Cost	Approx. AUD $8,000
Australia Cost	Approx. AUD $35,000
Quality Check	Exact CyberKnife case volume
Candidacy Check	Confirm suitability for the specific tumour
Follow-Up Check	Clear post-treatment imaging plan
Quote Requirement	Written, itemised quotation
Pre-Travel Records	Imaging and pathology
Follow-Up	Australian radiation oncology team
Warning Signs	Unclear candidacy, vague case volume or no named medical physicist
Patient Journey	Imaging → consultation → quote → travel → 5-session treatment → follow-up imaging
Decision Principle	Confirm candidacy and technology-specific expertise before comparing cost